FEATURED CONTENT

• How Unified Platform Approaches Deliver Up To 13x ROI

  Tufts CSDD outlines their argument as to why and how a decentralized clinical model can drive greater savings over time than traditional trials.

• You Don’t Have To Digitize Everything, You Just Have To Start

  Feeling left behind by the sudden digitization of clinical  trials? Learn how to take the right first step with this short blog. 

• What Keeps Patients From Enrolling In Clinical Trials?

  Explore five key reasons patients may opt not to participate in clinical trials and learn how technology can help overcome patients’ concerns. 

• PEAK Matrix® For Decentralized Clinical Trial Platforms Provider 2023

  Explore how technological advancements, innovative business models, increased wearables support, FDA’s push to the industry to adopt DCTs, and a holistic approach to clinical trials have proliferated the DCT landscape.

• Using Electronic COAs/PROs To Capture The Patient Experience

  As telehealth solutions and mobile health devices help empower decentralized clinical trials, discover how study sponsors look for ways to further improve the patient and site experience while delivering high-quality data.

• How Medable Increased Oncology Safety Monitoring By 90x

  Oncology trials placed a heavy burden on patients due to travel burden, poor patient experience and multi-year clinical trial commitments. Sites also struggle with cancer trials due to enrollment delays, complex data workflows, and multiple amendments requiring re-consents. Today, there is a more effective, patient-first solution.

• Why eConsent Primes Patients And Studies For Success

  In this white paper, learn how the informed consent process helps ensure trial participants are adequately educated about the trial and what will be required of them during the process, while confirming their willingness to enroll.

• How And Why To Include Patients In The Design Of Clinical Trials

  In this Q&A, learn from Rosamund Round, Vice President, Patient Innovation Center and Decentralized Trials at Parexel, on how to include patients in the design of clinical trials for the benefit of all stakeholders.

• Are Sites On Board With The Shift To Decentralized Clinical Trials (DCTs)?

  As the Senior Director and Co-Owner of Coastal Carolina Research Center, Nathan Morton provides strategic planning and operational oversight for a dedicated research center and clinical staff of 50.

• Why Pairing DCTs With Pharmacies Results In Better Participant Access

  A lack of access, awareness, and trust has caused an extreme lack of inclusivity in medical science. Discover a path forward for the industry that addresses diversity challenges using a combination of local pharmacy access and decentralized trial technologies.

• Recommendations For Optimizing Televisits

  Discover the pros and cons of telehealth visits and what can be done to continuously improve them.

• Call Centers And Clinical Trial

  Gain insight into why the call center must be viewed as an integral component of the clinical trial experience.

• Clinician Reported Outcomes: Let's Make It A Universal Language

  Discover the important role of clinician reported outcomes (ClinROs) when it comes to regulatory submissions.

• How To Avoid Selection Bias Through Proactive Action

  Learn how drug makers worldwide need to ensure that conditions for bias are not created as a result of access to devices or WiFi when it comes to clinical research.

• What Can Be Learned From The COVID-19 Vaccine Roll Out?

  The US has already achieved its target of 100 million Americans vaccinated in 100 days. Despite this huge milestone, discover how the registration for the vaccine itself has been anything but simple.

• Decentralized Clinical Trials: You Don’t Have To Do Everything, You Just Have To Start.

  Learn why you don't need to take an all-or-nothing approach when it comes to decentralized trials.

• Decentralized Clinical Trials Represent The Decentralization Of Care: What That Means For Patients

  At the beginning of the pandemic, thousands of clinical trials were suspended for the safety of investigators and participants alike. Once the FDA issued guidance for conducting trials virtually, discover the ways the industry embraced them and their benefits.

• Digital Biomarkers And Endpoints: Why They Matter In A DCT Setting

  Find out how digital biomarkers stand to have a profound impact on, and even enable, the digital transformation of the healthcare industry and DCTs.

• Patient Monitoring Starts With Consent: How To Be A Star At Doing Both Remotely

  Learn how decentralized clinical trials featuring technology-enabled communications are empowering researchers to create a more patient-centric clinical trial and transforming the clinical trial experience for patients.

• Kicking Off A Clinical Trial The Right Way - With Seamless Digital Consent

  Read this blog to learn more about how eConsent can enhance participant engagement and retention when used both onsite and remotely.